| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.25B | 69.87B | 68.09B | 63.32B | 69.98B | 45.31B |
| Gross Profit | 33.68B | 33.42B | 33.00B | 29.15B | 36.19B | 24.86B |
| EBITDA | 9.73B | 9.00B | 9.30B | 9.29B | 14.89B | 8.07B |
| Net Income | 4.44B | 3.70B | 3.50B | 4.41B | 8.34B | 3.04B |
Balance Sheet | ||||||
| Total Assets | 72.18B | 71.61B | 75.63B | 68.29B | 64.89B | 57.72B |
| Cash, Cash Equivalents and Short-Term Investments | 7.81B | 6.81B | 4.84B | 3.46B | 2.75B | 1.07B |
| Total Debt | 16.05B | 16.35B | 21.26B | 14.42B | 15.97B | 15.62B |
| Total Liabilities | 26.00B | 25.40B | 32.46B | 26.35B | 26.44B | 24.43B |
| Stockholders Equity | 46.19B | 46.21B | 43.15B | 41.93B | 38.45B | 33.28B |
Cash Flow | ||||||
| Free Cash Flow | 5.45B | 7.15B | -3.60B | 6.47B | 5.41B | 1.71B |
| Operating Cash Flow | 6.45B | 9.45B | 2.87B | 14.26B | 9.03B | 5.05B |
| Investing Cash Flow | -3.98B | -2.05B | -7.18B | -11.65B | -3.43B | -1.55B |
| Financing Cash Flow | -2.97B | -6.82B | 3.40B | -4.10B | -3.87B | -5.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹80.30B | 30.50 | ― | 3.28% | 3.01% | 22.98% | |
68 Neutral | ₹159.25B | 18.70 | ― | 1.13% | 2.50% | 6.26% | |
67 Neutral | ₹141.81B | 62.71 | ― | 0.45% | 6.34% | -2.25% | |
64 Neutral | ₹127.86B | 74.25 | ― | 1.84% | 0.75% | 37.44% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ₹113.71B | 23.92 | ― | 1.92% | 5.24% | 9.79% | |
46 Neutral | ₹145.71B | 272.89 | ― | 0.20% | ― | ― |